Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Jun Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9761-2502; OpenAlex author ID A5100433092. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. 18F-labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model. First author DOI 10.7150/jca.69710↗
  2. PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. First author DOI 10.1007/s00726-018-2566-y↗
  3. Targeting the hypoxia pathway to treat pancreatic cancer. Co-author DOI 10.2147/dddt.s80888↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaohui Wang · 2 shared papers, 2018–2022 · strength 0.30
  2. Yumin Li · 2 shared papers, 2018–2022 · strength 0.30
  3. Kai Chen · 1 shared paper, 2018 · strength 0.10
  4. Peiwen Fei · 1 shared paper, 2015 · strength 0.07
  5. Lori A. Erickson · 1 shared paper, 2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.